PubMed=30995489; DOI=10.1016/j.celrep.2019.03.047
MacLeod G., Bozek D.A., Rajakulendran N., Monteiro V., Ahmadi M., Steinhart Z., Kushida M.M., Yu H., Coutinho F.J., Cavalli F.M.G., Restall I.J., Hao X.-G., Hart T., Luchman H.A., Weiss S., Dirks P.B., Angers S.
Genome-wide CRISPR-Cas9 screens expose genetic vulnerabilities and mechanisms of temozolomide sensitivity in glioblastoma stem cells.
Cell Rep. 27:971-986.e9(2019)

PubMed=31249064; DOI=10.1101/gr.246520.118; PMCID=PMC6673710
Johnston M.J., Nikolic A., Ninkovic N.A., Guilhamon P., Cavalli F.M.G., Seaman S., Zemp F.J., Lee J., Abdelkareem A., Ellestad K., Murison A., Kushida M.M., Coutinho F.J., Ma Y., Mungall A.J., Moore R., Marra M.A., Taylor M.D., Dirks P.B., Pugh T.J., Morrissy A.S., St Croix B., Mahoney D.J., Lupien M., Gallo M.
High-resolution structural genomics reveals new therapeutic vulnerabilities in glioblastoma.
Genome Res. 29:1211-1222(2019)

DOI=10.1021/acsmaterialsau.3c00029
Smith L.J., Skirzynska A., Chin A.A., Arnold A.E., Kushida M.M., Dirks P.B., Shoichet M.S.
Engineered in vitro tumor model recapitulates molecular signatures of invasion in glioblastoma.
ACS Materials Au 3:514-527(2023)

PubMed=36989359; DOI=10.1126/sciadv.ade5321; PMCID=PMC10058241
Wang X., Gong Z.-Y., Wang T.-C., Law J.-H., Chen X., Wanggou S.-Y., Wang J.-T., Ying B.-B., Francisco M.A., Dong W.-F., Xiong Y., Fan J.J., MacLeod G., Angers S., Li X.-J., Dirks P.B., Liu X.-Y., Huang X., Sun Y.
Mechanical nanosurgery of chemoresistant glioblastoma using magnetically controlled carbon nanotubes.
Sci. Adv. 9:eade5321.1-eade5321.14(2023)